Orchid Pharma

Orchid Pharma Current Liabilities

The Current Liabilities of Orchid Pharma (ORCHPHARMA.NS) as of Nov 6, 2026 is 2.79 B INR. In the previous year, Current Liabilities was 2.86 B INR — a change of -2.42% (lower).

Current Liabilities

2.79 BINR

YoY

-2.42%

Last updated:

Current Liabilities of Orchid Pharma is 2026 2.79 B INR. Current Liabilities of Orchid Pharma was 2025 2.86 B INR. It decreases by -2.42% lower compared to the previous year.

The Orchid Pharma Current Liabilities history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Current Liabilities
Date
Current Liabilities
Jan 1, 2019
23.46 B INR
Jan 1, 2020
2.37 B INR
Jan 1, 2021
1.64 B INR
Jan 1, 2022
2.78 B INR
Jan 1, 2023
4.12 B INR
Jan 1, 2024
2.61 B INR
Jan 1, 2025
2.86 B INR
Jan 1, 2026
2.79 B INR
The Orchid Pharma Current Liabilities history
YEARCurrent LiabilitiesYoY
2.79 BINR-2.42%
2.86 BINR+9.69%
2.61 BINR-36.70%
4.12 BINR+48.29%
2.78 BINR+68.86%
1.64 BINR-30.71%
2.37 BINR-89.88%
23.46 BINR+2.60%
22.86 BINR+22.91%
18.60 BINR+20.71%
15.41 BINR+12.41%
13.71 BINR-57.24%
32.06 BINR+78.90%
17.92 BINR-32.41%
26.51 BINR+172.83%
9.72 BINR+13.55%
8.56 BINR+16.63%
7.34 BINR+10.39%
6.65 BINR+148.02%
2.68 BINR-1.63%
2.72 BINR-44.70%
4.93 BINR+262.56%
1.36 BINR+72.46%
788.00 MINR+20.67%
653.00 MINR+6.35%
614.00 MINR+2.85%
597.00 MINR+39.81%
427.00 MINR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Orchid Pharma Stock analysis

What does Orchid Pharma do? Orchid Pharma is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Orchid Pharma stock

Current Liabilities of Orchid Pharma is 2.79 B INR in 2026.

Current Liabilities of Orchid Pharma changed from 2.86 B INR to 2.79 B INR, representing a -2.42% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Current Liabilities Orchid Pharma since 2006 – with annual values, charts, and detailed analysis.

Current liabilities are obligations due within one year, including accounts payable, short-term debt, and accrued expenses.

Current Liabilities's INR is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track Current Liabilities's Orchid Pharma historically and in real time.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Balance Sheet — Orchid Pharma

Total AssetsCurrent AssetsCash & EquivalentsReceivablesInventoryProperty, Plant & EquipmentGoodwillIntangible AssetsEquityLiabilitiesDebtCurrent LiabilitiesLong-term DebtShort-term DebtRetained EarningsBook Value per ShareTangible Book Value per ShareWorking CapitalInvestmentsAccounts PayableNon-Current AssetsShort-Term InvestmentsLong-Term InvestmentsNet DebtTreasury StockMinority InterestDeferred Tax LiabilitiesNet Tangible AssetsGoodwill/AssetsIntangibles/Assets

All Key Metrics — Orchid Pharma